T. Rowe Price Associates
RPID icon

T. Rowe Price Associates’s Rapid Micro Biosystems RPID Stock Holding History

T. Rowe Price Associates’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-760,438
Closed -$997K – 2936
2023
Q1 		$997K Sell
760,438
-40,066
-5% -$52K ﹤0.01% 1791
2022
Q4 		$905K Sell
800,504
-37,351
-4% -$90.4K ﹤0.01% 1820
2022
Q3 		$2.71M Sell
837,855
-2,589,299
-76% -$10M ﹤0.01% 1339
2022
Q2 		$14.7M Sell
3,427,154
-20,032
-0.6% -$93.2K ﹤0.01% 1243
2022
Q1 		$23.4M Buy
3,447,186
+1,247,440
+57% +$9.19M ﹤0.01% 1194
2021
Q4 		$23.2M Buy
2,199,746
+343,704
+19% +$5.37M ﹤0.01% 1250
2021
Q3 		$33.9M Buy
+1,856,042
New +$38.3M ﹤0.01% 1149

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return